CRRT Filtersets
Vantive CRRT filtersets maximize simplicity and efficiency
Each CRRT filterset can be used with all CRRT modalities and with any anticoagulant protocol, so there is no need to list multiple types on the order set or to keep several types in inventory. CRRT modalities can be changed during therapy without changing the set.
Compatible Products
Acute Therapy Systems
CRRT Solutions
Organ Support Filtersets
Digital Solutions
Suitable for all CRRT prescriptions
Each CRRT filterset works with all CRRT modalities and any anticoagulant protocol, providing flexibility to meet patient needs and create operational efficiencies.
Unique clearance mechanism
Vantive’s AN69ST membrane has a unique mechanism of action that adsorbs1 the higher-molecular-weight toxins that can be present in patients with AKI.
Exclusively for PrisMax and Prismaflex systems
Engineered to work with the PrisMax and Prismaflex systems, Vantive’s CRRT filtersets are bar-coded for set recognition, with step-by-step setup guidance supporting reduced downtime and lasting therapy proficiency.2
Simplify therapy set-up and management
Vantive CRRT filters are permanently pre-connected to color-coded tubing lines for easy setup and accurate connection between lines and bags.3 Each set is a closed system, minimizing setup steps and reducing the potential for touch contamination.3
The pre-connected filtersets have a specifically designed deaeration chamber to help remove air without user intervention, eliminate the blood and air interface, and reduce blood clot formation.2
Membrane | Minimal patient size | SCUF | CVVH | CVVHD | CVVHDF | Heparin | No anti-coagulant | |
ST60 | AN69ST | 11 kg | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
ST100 | AN69ST | 30 kg | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
ST150 | AN69ST | 30 kg | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Membrane options to fit individual patient needs
Vantive’s CRRT filtersets include options for adult patients and for low-body-weight patients, all with lower extracorporeal blood volumes.
Vantive CRRT filtersets feature the unique AN69ST membrane for exceptional biocompatibility and a unique adsorptive capability to clear the higher-molecular-weight toxins that may be present in patients with AKI.1
ST60 set | ST100 set | ST150 set | |
Membrane effective surface area | 0.6 m2 | 1 m2 | 1.5 m2 |
Blood volume in set | 97 mL | 155 mL | 193 mL |
Minimal patient weight | 11 kg | 30 kg | 30 kg |
Important Safety Information
INTENDED USE
The Prismaflex and PrisMax Systems are intended for:
- Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload.
- Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated.
INTENDED USE
The Prismaflex ST set is a single-use device that provides blood purification through a semipermeable membrane. The Prismaflex ST set is for use only in conjunction with the Prismaflex control unit or with the PrisMax control unit (in countries where PrisMax is cleared or registered). All treatments administered via the Prismaflex ST sets must be prescribed by a physician. The size, weight, state of uremia, cardiac status, and general physical condition of the patient must be carefully evaluated by the prescribing physician before each treatment.
If patients suffer from acute kidney injury and / or volume overload, the Prismaflex ST set is indicated for continuous renal replacement therapies (CRRT), in modalities such as:
- Slow Continuous UltraFiltration (SCUF)
- Continuous Veno-Venous Hemofiltration (CVVH)
- Continuous Veno-Venous HemoDialysis (CVVHD)
- Continuous Veno-Venous HemoDiaFiltration (CVVHDF) to perform fluid management and reduction of uremic toxins.
The Prismaflex ST100 set and ST150 are indicated for use in patients with a body weight equal or greater than 30kg (66lb) and Prismaflex ST60 set is indicated to patients with a body weight greater than 11kg (24lb).
Rx Only. For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.
Vantive, AN69, Prismaflex and PrisMax and are trademarks of Vantive Health LLC or its affiliates.
References
-
Thomas M, Moriyama K, Ledebo I. AN69ST: Evolution of the world's first high permeability membrane. Contrib Nephrol. 2011;173:119-129.
-
Vantive Health LLC. PrisMax Operator’s Manual. AW8061. May, 2022.
-
Vantive Health LLC. ST60/ST100/ST150 sets with AN69 Spec Sheet. 1000015673. August, 2024. Internal Documentation.
-
Vantive Health LLC. FMC Product Range Acute Therapies, 2014. Internal Documentation.